Addus HomeCare Announces First-Quarter 2021 Financial Results
Revenue Increases 7.9% to
Net Income Increases to
Adjusted EBITDA Increases 8.9% to
Net service revenues were
Adjusted net income per diluted share for the first quarter of 2021 excludes acquisition and de novo expenses of
As of
“We continue to see improving organic growth trends ahead of pre-pandemic levels in both personal care and home health. With the accelerating growth in vaccinations across the country and increasing facility access, we expect that we will begin to see a return to higher volume trends in our hospice business. Ultimately, we believe Addus is well positioned to meet expected demand in all our operating segments as overall conditions improve and more restrictions are lifted.
“We also expect to benefit from the statewide
Non-GAAP Financial Measures
The information provided in this release includes adjusted net income, adjusted EBITDA and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before the net COVID-19 expenses, acquisition and de novo expenses, stock-based compensation expense, restructure expenses, and other costs. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation, amortization, net COVID-19 expenses, acquisition and de novo expenses, stock-based compensation expense, restructure expenses, and other costs. The Company defines adjusted diluted earnings per share as earnings per share, adjusted for net COVID-19 expenses, acquisition and de novo expenses, stock compensation expense, restructure expenses, and other costs. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted earnings per share to earnings per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted earnings per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers. With respect to net COVID-19 expenses, the Company views these expenses as unrelated to the Company’s long-term performance, since they are directly related to the sudden onset COVID-19 pandemic.
Conference Call
Addus will host a conference call on
Forward-Looking Statements
Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, anticipated transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, the anticipated impact to our business operations, reimbursements and patient population due to the recent COVID-19 global pandemic, caused by a novel strain of the coronavirus (COVID-19), and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the
About
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||
Condensed Consolidated Statements of Income | |||||||
(amounts and shares in thousands, except per share data) | |||||||
(Unaudited) | |||||||
Income Statement Information: |
For the Three Months Ended |
||||||
|
2021 |
|
|
|
2020 |
|
|
Net service revenues |
$ |
205,302 |
|
$ |
190,216 |
|
|
Cost of service revenues |
|
144,105 |
|
|
134,381 |
|
|
Gross profit |
|
61,197 |
|
|
55,835 |
|
|
|
29.8 |
% |
|
29.4 |
% |
||
General and administrative expenses |
|
45,426 |
|
|
42,287 |
|
|
Depreciation and amortization |
|
3,601 |
|
|
2,887 |
|
|
Total operating expenses |
|
49,027 |
|
|
45,174 |
|
|
Operating income from continuing operations |
|
12,170 |
|
|
10,661 |
|
|
Total interest expense, net |
|
1,194 |
|
|
574 |
|
|
Income before income taxes |
|
10,976 |
|
|
10,087 |
|
|
Income tax expense |
|
2,082 |
|
|
1,429 |
|
|
Net income |
$ |
8,894 |
|
$ |
8,658 |
|
|
Net income per diluted share: |
$ |
0.55 |
|
$ |
0.54 |
|
|
Weighted average number of common shares outstanding: | |||||||
Diluted |
|
16,069 |
|
|
15,907 |
|
|
Cash Flow Information: |
For the Three Months Ended |
||||||
|
2021 |
|
|
|
2020 |
|
|
Net cash (used in) provided by operating activities |
$ |
(18,366 |
) |
$ |
20,442 |
|
|
Net cash (used in) investing activities |
|
(1,021 |
) |
|
(2,834 |
) |
|
Net cash (used in) provided by financing activities |
|
(144 |
) |
|
1,141 |
|
|
Net change in cash |
|
(19,531 |
) |
|
18,749 |
|
|
Cash at the beginning of the period |
|
145,078 |
|
|
111,714 |
|
|
Cash at the end of the period |
$ |
125,547 |
|
$ |
130,463 |
|
|
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||
Condensed Consolidated Balance Sheets | |||||
(Amounts in thousands) | |||||
(Unaudited) | |||||
|
|||||
|
2021 |
|
|
2020 |
|
Assets | |||||
Current assets | |||||
Cash |
$ |
125,547 |
$ |
130,463 |
|
Accounts receivable, net |
|
138,806 |
|
141,083 |
|
Prepaid expenses and other current assets |
|
10,787 |
|
6,505 |
|
Total current assets |
|
275,140 |
|
278,051 |
|
Property and equipment, net |
|
19,322 |
|
13,791 |
|
Other assets | |||||
|
469,036 |
|
275,364 |
||
Intangible assets, net |
|
69,395 |
|
55,304 |
|
Deferred tax assets, net |
|
6,359 |
|
1,606 |
|
Operating lease assets |
|
38,325 |
|
20,703 |
|
Total other assets |
|
583,115 |
|
352,977 |
|
Total assets |
$ |
877,577 |
$ |
644,819 |
|
Liabilities and stockholders' equity | |||||
Current liabilities | |||||
Accounts payable |
$ |
23,459 |
$ |
17,561 |
|
Accrued payroll |
|
20,255 |
|
29,476 |
|
Accrued expenses |
|
38,654 |
|
22,116 |
|
Government stimulus advance |
|
20,368 |
|
- |
|
Accrued workers compensation |
|
14,380 |
|
14,497 |
|
Current portion of long-term debt |
|
972 |
|
956 |
|
Total current liabilities |
|
118,088 |
|
84,606 |
|
Long-term debt, less current portion, net of debt issuance costs |
|
193,839 |
|
59,112 |
|
Long-term operating lease liabilities, less current portion |
|
35,623 |
|
13,638 |
|
Other long-term liabilities |
|
117 |
|
655 |
|
Total long-term liabilities |
|
229,579 |
|
73,405 |
|
Total liabilities |
|
347,667 |
|
158,011 |
|
Total stockholders' equity |
|
529,910 |
|
486,808 |
|
Total liabilities and stockholders' equity |
$ |
877,577 |
$ |
644,819 |
|
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||
Net Service Revenues by Segment | |||||
(Amounts in thousands) | |||||
(Unaudited) | |||||
For the Three Months Ended |
|||||
|
2021 |
|
|
2020 |
|
Personal Care |
$ |
164,868 |
$ |
160,665 |
|
Hospice |
|
36,094 |
|
25,212 |
|
|
4,340 |
|
4,339 |
||
Total Revenue |
$ |
205,302 |
$ |
190,216 |
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||
Key Statistical and Financial Data (Unaudited) | ||||||
For the Three Months
Ended |
||||||
|
2021 |
|
|
2020 |
||
Personal Care | ||||||
States served at period end |
|
21 |
|
|
24 |
|
Locations served at period end |
|
164 |
|
|
151 |
|
Average billable census - same store |
|
36,788 |
|
|
39,170 |
|
Average billable census - acquisitions (1) |
|
1,539 |
|
|
- |
|
Average billable census total (2) |
|
38,327 |
|
|
39,170 |
|
Billable hours (in thousands) |
|
7,567 |
|
|
7,674 |
|
Average billable hours per census per month |
|
65.2 |
|
|
64.9 |
|
Billable hours per business day |
|
118,237 |
|
|
118,054 |
|
Revenues per billable hour |
$ |
21.75 |
|
$ |
20.97 |
|
Organic growth | ||||||
- Revenue |
|
2.4 |
% |
|
14.0 |
% |
Hospice | ||||||
Locations served at period end |
|
34 |
|
|
34 |
|
Admissions |
|
2,394 |
|
|
1,655 |
|
Average daily census |
|
2,400 |
|
|
1,863 |
|
Average discharge length of stay |
|
101.3 |
|
|
99.1 |
|
Patient days |
|
216,007 |
|
|
169,512 |
|
Revenue per patient day |
$ |
167.09 |
|
$ |
150.49 |
|
Organic growth | ||||||
- Revenue |
|
(8.4 |
)% |
|
12.1 |
% |
- Average daily census |
|
(20.2 |
)% |
|
14.1 |
% |
Locations served at period end |
|
10 |
|
|
10 |
|
New Admissions |
|
1,168 |
|
|
1,022 |
|
Recertifications |
|
657 |
|
|
710 |
|
Total Volume |
|
1,825 |
|
|
1,732 |
|
Visits |
|
27,665 |
|
|
33,710 |
|
Organic growth | ||||||
- Revenue |
|
0.0 |
% |
|
19.5 |
% |
- Total volume |
|
5.4 |
% |
|
6.6 |
% |
Percentage of Revenues by Payor: | ||||||
Personal Care | ||||||
State, local and other governmental programs |
|
49.0 |
% |
|
49.4 |
% |
Managed care organizations |
|
45.8 |
|
|
44.9 |
|
Private duty |
|
3.0 |
|
|
3.3 |
|
Commercial |
|
1.4 |
|
|
1.6 |
|
Other |
|
0.8 |
% |
|
0.8 |
% |
Hospice | ||||||
Medicare |
|
94.2 |
% |
|
92.1 |
% |
Managed care organizations |
|
4.1 |
|
|
5.5 |
|
Other |
|
1.7 |
% |
|
2.4 |
% |
Medicare |
|
80.7 |
% |
|
80.0 |
% |
Managed care organizations |
|
18.4 |
|
|
18.6 |
|
Other |
|
0.9 |
% |
|
1.4 |
% |
(1) The average billable census in acquisitions of 993 for the three ended |
|||||
(2) Exited sites would have reduced same store census for the three months ended |
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||
Reconciliation of Non-GAAP Financial Measures | |||||||
(Amounts in thousands, except per share data) | |||||||
(Unaudited) | |||||||
For the Three Months
Ended |
|||||||
|
2021 |
|
|
|
2020 |
|
|
Reconciliation of Adjusted EBITDA to Net Income: (1) | |||||||
Net income |
$ |
8,894 |
|
$ |
8,658 |
|
|
Interest expense, net |
|
1,194 |
|
|
574 |
|
|
Income tax expense |
|
2,082 |
|
|
1,429 |
|
|
Depreciation and amortization |
|
3,601 |
|
|
2,887 |
|
|
COVID-19 expense, net |
|
(591 |
) |
|
263 |
|
|
Acquisition and de novo expenses |
|
1,475 |
|
|
1,634 |
|
|
Stock-based compensation expense |
|
2,239 |
|
|
1,407 |
|
|
Restructuring and other costs |
|
402 |
|
|
873 |
|
|
Adjusted EBITDA |
$ |
19,296 |
|
$ |
17,725 |
|
|
Reconciliation of Adjusted Net Income to Net Income: (2) | |||||||
Net income |
$ |
8,894 |
|
$ |
8,658 |
|
|
COVID-19 expense, net of tax |
|
(479 |
) |
|
227 |
|
|
Acquisition and de novo expenses, net of tax |
|
1,352 |
|
|
1,417 |
|
|
Stock-based compensation expense, net of tax |
|
1,814 |
|
|
1,220 |
|
|
Restructuring and other costs, net of tax |
|
326 |
|
|
758 |
|
|
Adjusted Net Income |
|
11,907 |
|
|
12,280 |
|
|
Reconciliation of Diluted Earnings per Share to Adjusted Diluted Earnings per Share: (3) | |||||||
Diluted earnings per share |
$ |
0.55 |
|
$ |
0.54 |
|
|
COVID-19 expense, net per diluted share |
|
(0.03 |
) |
|
0.01 |
|
|
Acquisition and de novo expenses, per diluted share |
|
0.08 |
|
|
0.09 |
|
|
Restructuring and other costs per diluted share |
|
0.02 |
|
|
0.05 |
|
|
Stock-based compensation expense per diluted share |
|
0.12 |
|
|
0.08 |
|
|
Adjusted net income per diluted share |
$ |
0.74 |
|
$ |
0.77 |
|
|
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4) | |||||||
Net service revenues |
$ |
205,302 |
|
$ |
190,216 |
|
|
Revenue associated with the closure of certain sites |
|
2 |
|
|
(2,078 |
) |
|
Adjusted net service revenues |
$ |
205,304 |
|
$ |
188,138 |
|
|
(1) We define Adjusted EBITDA as earnings before interest expense, taxes, depreciation, amortization, net COVID-19 expenses, acquisition and de novo expenses, stock-based compensation expense, restructure expenses, and other costs. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in |
||||
(2) We define Adjusted Net Income as net income before net COVID-19 expenses, acquisition and de novo expenses, stock-based compensation expense, restructure expenses, and other costs. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in |
||||
(3) We define Adjusted diluted earnings per share as earnings per share, adjusted for net COVID-19 expenses, acquisition and de novo expenses, stock compensation expense and restructure expenses, and other costs. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in |
||||
(4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005673/en/
Executive Vice President,
Chief Financial Officer
(469) 535-8200
investorrelations@addus.com
(615) 324-7346
dru.anderson@cci-ir.com
Source: